GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. Duke, and Alex Franzusoff on February 10, 1995 and is headquartered in Louisville, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of GlobeImmune Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. GlobeImmune Inc market cap is $6.00.
What is the 52-week high for GlobeImmune Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GlobeImmune Inc 52 week high is $0.0001 as of July 13, 2026.
What was GlobeImmune Inc stock price yesterday?
GlobeImmune Inc stock price yesterday was $0.0001.